Effects of recombinant bovine interleukin-8 (rbIL-8) treatment on health, metabolism, and lactation performance in Holstein cattle II: Postpartum uterine health, ketosis, and milk production

J Dairy Sci. 2019 Nov;102(11):10316-10328. doi: 10.3168/jds.2019-16335. Epub 2019 Sep 5.

Abstract

To evaluate the effect of recombinant bovine interleukin-8 (rbIL-8) on uterine health and milk production, 2 separate studies were conducted. For study 1, postpartum Holstein cows (n = 213) were randomly allocated into 1 of 3 intrauterine treatment groups: control (CTR, 250 mL of saline solution), low dose (L-IL8, 11.25 µg of rbIL-8 diluted in 250 mL of saline solution), and high dose (H-IL8, 1,125 µg of rbIL-8 diluted in 250 mL of saline solution). Intrauterine delivery of treatments was performed within 12 h of parturition. Cows were evaluated for retained fetal membranes, puerperal metritis, and clinical endometritis. Blood samples were collected immediately before treatment and 1, 2, and 3 d in milk for assessment of IL-8, haptoglobin, fatty acids, and β-hydroxybutyrate concentrations. Treatment with rbIL-8 reduced the incidence of puerperal metritis in multiparous cows (CTR = 34.3, L-IL8 = 8.11, and H-IL8 = 6.35%). Both the L-IL8 and H-IL8 groups produced significantly more milk, fat-corrected milk, and energy-corrected milk yields when compared with placebo-treated controls. A second study was performed to confirm the effect of rbIL-8 on milk production. In study 2, 164 primiparous cows were randomly allocated into 1 of 4 treatment groups: control (CTR, 250 mL of saline solution), low dose (L-IL8, 0.14 µg of rbIL-8), medium dose (M-IL8, 14 µg of rbIL-8), and high dose (H-IL8, 1,400 µg of rbIL-8). Treatments were prepared and administered as described for study 1. Cows in the L-IL8, M-IL8, and H-IL8 groups produced significantly more milk, fat-corrected milk, and energy-corrected milk yields when compared with control cows. In conclusion, treatment with rbIL-8 decreased the incidence of puerperal metritis in multiparous cows. The administration of rbIL-8 was repeatedly associated with a dramatic and long-lasting improvement of lactation performance.

Keywords: interleukin-8; metabolism; milk production; puerperal metritis.

Publication types

  • Randomized Controlled Trial, Veterinary
  • Validation Study

MeSH terms

  • 3-Hydroxybutyric Acid / blood
  • Animals
  • Cattle / immunology
  • Cattle / metabolism
  • Cattle / physiology*
  • Cattle Diseases / metabolism
  • Cattle Diseases / physiopathology
  • Cattle Diseases / prevention & control*
  • Chemotaxis
  • Endometritis / prevention & control
  • Endometritis / veterinary
  • Female
  • Fermentation
  • Haptoglobins / metabolism
  • Health Status
  • Interleukin-8 / administration & dosage
  • Interleukin-8 / blood
  • Interleukin-8 / genetics
  • Interleukin-8 / pharmacology*
  • Ketosis / metabolism
  • Ketosis / physiopathology
  • Ketosis / prevention & control
  • Ketosis / veterinary*
  • Lactation / drug effects*
  • Milk / chemistry
  • Parity
  • Parturition
  • Placenta, Retained / prevention & control
  • Placenta, Retained / veterinary
  • Postpartum Period
  • Pregnancy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / blood
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology

Substances

  • Haptoglobins
  • Interleukin-8
  • Recombinant Proteins
  • 3-Hydroxybutyric Acid